COPD (Chronic Obstructive Pulmonary Disease) Clinical Trials

A listing of COPD (Chronic Obstructive Pulmonary Disease) medical research trials actively recruiting patient volunteers. Click on the closest city to find more detailed information on a research study in your area.

 

Alabama

UPDATED

Andalusia Alabama

A clinical research study of BGF MDI 320/14.4/9.6 μg, GFF MDI 14.4/9.6 μg, BGF MDI 160/14.4/9.6 μg and BFF MDI 320/9.6 μg for the treatment of COPD

UPDATED

Athens Alabama

A clinical research study of BGF MDI 320/14.4/9.6 μg, GFF MDI 14.4/9.6 μg, BGF MDI 160/14.4/9.6 μg and BFF MDI 320/9.6 μg for the treatment of COPD

UPDATED

Birmingham Alabama

A clinical research study of BGF MDI 320/14.4/9.6 μg, GFF MDI 14.4/9.6 μg, BGF MDI 160/14.4/9.6 μg and BFF MDI 320/9.6 μg for the treatment of COPD

UPDATED

Birmingham Alabama 35243

A clinical trial to evaluate treatments using Danirixin, Danirixin matching placebo, Standard of care and Rescue medication for patients with Pulmonary Disease, Chronic Obstructive

UPDATED

Jasper Alabama

A clinical research study of BGF MDI 320/14.4/9.6 μg, GFF MDI 14.4/9.6 μg, BGF MDI 160/14.4/9.6 μg and BFF MDI 320/9.6 μg for the treatment of COPD

View More ▼

UPDATED

Mobile Alabama

A clinical research study of BGF MDI 320/14.4/9.6 μg, GFF MDI 14.4/9.6 μg, BGF MDI 160/14.4/9.6 μg and BFF MDI 320/9.6 μg for the treatment of COPD

Arizona

UPDATED

Peoria Arizona

A clinical research study of BGF MDI 320/14.4/9.6 μg, GFF MDI 14.4/9.6 μg, BGF MDI 160/14.4/9.6 μg and BFF MDI 320/9.6 μg for the treatment of COPD

UPDATED

Phoenix Arizona 85018

A clinical research study for the treatment of Pulmonary Disease, Chronic Obstructive

UPDATED

Phoenix Arizona

A clinical research study of BGF MDI 320/14.4/9.6 μg, GFF MDI 14.4/9.6 μg, BGF MDI 160/14.4/9.6 μg and BFF MDI 320/9.6 μg for the treatment of COPD

California

UPDATED

Bakersfield California

A clinical research study of BGF MDI 320/14.4/9.6 μg, GFF MDI 14.4/9.6 μg, BGF MDI 160/14.4/9.6 μg and BFF MDI 320/9.6 μg for the treatment of COPD

UPDATED

Fountain Valley California

A clinical research study of BGF MDI 320/14.4/9.6 μg, GFF MDI 14.4/9.6 μg, BGF MDI 160/14.4/9.6 μg and BFF MDI 320/9.6 μg for the treatment of COPD

UPDATED

Lincoln California 95648

A clinical research study for the treatment of Pulmonary Disease, Chronic Obstructive

UPDATED

Los Angeles California

A clinical research study of BGF MDI 320/14.4/9.6 μg, GFF MDI 14.4/9.6 μg, BGF MDI 160/14.4/9.6 μg and BFF MDI 320/9.6 μg for the treatment of COPD

UPDATED

Palmdale California

A clinical research study of BGF MDI 320/14.4/9.6 μg, GFF MDI 14.4/9.6 μg, BGF MDI 160/14.4/9.6 μg and BFF MDI 320/9.6 μg for the treatment of COPD

View More ▼

UPDATED

Poway California

A clinical research study of BGF MDI 320/14.4/9.6 μg, GFF MDI 14.4/9.6 μg, BGF MDI 160/14.4/9.6 μg and BFF MDI 320/9.6 μg for the treatment of COPD

UPDATED

Rancho Mirage California

A clinical research study of BGF MDI 320/14.4/9.6 μg, GFF MDI 14.4/9.6 μg, BGF MDI 160/14.4/9.6 μg and BFF MDI 320/9.6 μg for the treatment of COPD

UPDATED

San Diego California

A clinical research study of BGF MDI 320/14.4/9.6 μg, GFF MDI 14.4/9.6 μg, BGF MDI 160/14.4/9.6 μg and BFF MDI 320/9.6 μg for the treatment of COPD

UPDATED

Stockton California

A clinical research study of BGF MDI 320/14.4/9.6 μg, GFF MDI 14.4/9.6 μg, BGF MDI 160/14.4/9.6 μg and BFF MDI 320/9.6 μg for the treatment of COPD

Colorado

UPDATED

Colorado Springs Colorado 80907

A clinical trial to evaluate treatments using Blood draw, Urine, Lung function measurements and Fractional Exhaled Nitric Oxide (FENO) for patients with Asthma, COPD or Chronic Obstructive Pulmonary Disease

Florida

UPDATED

Boynton Beach Florida

A clinical research study of BGF MDI 320/14.4/9.6 μg, GFF MDI 14.4/9.6 μg, BGF MDI 160/14.4/9.6 μg and BFF MDI 320/9.6 μg for the treatment of COPD

UPDATED

Clearwater Florida 33765

A clinical research study for the treatment of Pulmonary Disease, Chronic Obstructive

UPDATED

Clearwater Florida

A clinical research study of BGF MDI 320/14.4/9.6 μg, GFF MDI 14.4/9.6 μg, BGF MDI 160/14.4/9.6 μg and BFF MDI 320/9.6 μg for the treatment of COPD

UPDATED

Clearwater Florida 33765

A clinical trial to evaluate treatments using Blood draw, Urine, Lung function measurements and Fractional Exhaled Nitric Oxide (FENO) for patients with Asthma, COPD or Chronic Obstructive Pulmonary Disease

UPDATED

Clermont Florida

A clinical research study of BGF MDI 320/14.4/9.6 μg, GFF MDI 14.4/9.6 μg, BGF MDI 160/14.4/9.6 μg and BFF MDI 320/9.6 μg for the treatment of COPD

View More ▼

UPDATED

Coral Gables Florida

A clinical research study of BGF MDI 320/14.4/9.6 μg, GFF MDI 14.4/9.6 μg, BGF MDI 160/14.4/9.6 μg and BFF MDI 320/9.6 μg for the treatment of COPD

UPDATED

Daytona Beach Florida

A clinical research study of BGF MDI 320/14.4/9.6 μg, GFF MDI 14.4/9.6 μg, BGF MDI 160/14.4/9.6 μg and BFF MDI 320/9.6 μg for the treatment of COPD

UPDATED

Gainesville Florida

A clinical research study of BGF MDI 320/14.4/9.6 μg, GFF MDI 14.4/9.6 μg, BGF MDI 160/14.4/9.6 μg and BFF MDI 320/9.6 μg for the treatment of COPD

UPDATED

Gainesville Florida 32608-1197

A clinical trial to evaluate treatments using Blood draw, Urine, Lung function measurements and Fractional Exhaled Nitric Oxide (FENO) for patients with Asthma, COPD or Chronic Obstructive Pulmonary Disease

UPDATED

Hialeah Florida

A clinical research study of BGF MDI 320/14.4/9.6 μg, GFF MDI 14.4/9.6 μg, BGF MDI 160/14.4/9.6 μg and BFF MDI 320/9.6 μg for the treatment of COPD

UPDATED

Hollywood Florida

A clinical research study of BGF MDI 320/14.4/9.6 μg, GFF MDI 14.4/9.6 μg, BGF MDI 160/14.4/9.6 μg and BFF MDI 320/9.6 μg for the treatment of COPD

UPDATED

Kissimmee Florida

A clinical research study of BGF MDI 320/14.4/9.6 μg, GFF MDI 14.4/9.6 μg, BGF MDI 160/14.4/9.6 μg and BFF MDI 320/9.6 μg for the treatment of COPD

UPDATED

Miami Florida

A clinical research study of BGF MDI 320/14.4/9.6 μg, GFF MDI 14.4/9.6 μg, BGF MDI 160/14.4/9.6 μg and BFF MDI 320/9.6 μg for the treatment of COPD

UPDATED

Miami Florida 33032

A clinical trial to evaluate treatments using Blood draw, Urine, Lung function measurements and Fractional Exhaled Nitric Oxide (FENO) for patients with Asthma, COPD or Chronic Obstructive Pulmonary Disease

UPDATED

Miami Florida 33125

A clinical trial to evaluate treatments using Blood draw, Urine, Lung function measurements and Fractional Exhaled Nitric Oxide (FENO) for patients with Asthma, COPD or Chronic Obstructive Pulmonary Disease

UPDATED

Miami Lakes Florida

A clinical research study of BGF MDI 320/14.4/9.6 μg, GFF MDI 14.4/9.6 μg, BGF MDI 160/14.4/9.6 μg and BFF MDI 320/9.6 μg for the treatment of COPD

UPDATED

Orlando Florida 32825

A clinical research study for the treatment of Pulmonary Disease, Chronic Obstructive

UPDATED

Orlando Florida 32825

Patients are needed to participate in a clinical research study of ELLIPTA placebo DPI, DISKUS placebo DPI, HandiHaler DPI and Inhaler preference questionnaires to evaluate Pulmonary Disease, Chronic Obstructive

UPDATED

Ormond Beach Florida

A clinical research study of BGF MDI 320/14.4/9.6 μg, GFF MDI 14.4/9.6 μg, BGF MDI 160/14.4/9.6 μg and BFF MDI 320/9.6 μg for the treatment of COPD

UPDATED

Panama City Florida

A clinical research study of BGF MDI 320/14.4/9.6 μg, GFF MDI 14.4/9.6 μg, BGF MDI 160/14.4/9.6 μg and BFF MDI 320/9.6 μg for the treatment of COPD

UPDATED

Pasadena Florida

A clinical research study of BGF MDI 320/14.4/9.6 μg, GFF MDI 14.4/9.6 μg, BGF MDI 160/14.4/9.6 μg and BFF MDI 320/9.6 μg for the treatment of COPD

UPDATED

Pensacola Florida

A clinical research study of BGF MDI 320/14.4/9.6 μg, GFF MDI 14.4/9.6 μg, BGF MDI 160/14.4/9.6 μg and BFF MDI 320/9.6 μg for the treatment of COPD

UPDATED

Plantation Florida 33317

A clinical trial to evaluate treatments using Blood draw, Urine, Lung function measurements and Fractional Exhaled Nitric Oxide (FENO) for patients with Asthma, COPD or Chronic Obstructive Pulmonary Disease

UPDATED

Tamarac Florida

A clinical research study of BGF MDI 320/14.4/9.6 μg, GFF MDI 14.4/9.6 μg, BGF MDI 160/14.4/9.6 μg and BFF MDI 320/9.6 μg for the treatment of COPD

UPDATED

Tampa Florida 33603

A clinical research study for the treatment of Pulmonary Disease, Chronic Obstructive

UPDATED

Tampa Florida

A clinical research study of BGF MDI 320/14.4/9.6 μg, GFF MDI 14.4/9.6 μg, BGF MDI 160/14.4/9.6 μg and BFF MDI 320/9.6 μg for the treatment of COPD

UPDATED

Wellington Florida

A clinical research study of BGF MDI 320/14.4/9.6 μg, GFF MDI 14.4/9.6 μg, BGF MDI 160/14.4/9.6 μg and BFF MDI 320/9.6 μg for the treatment of COPD

UPDATED

Winter Park Florida

A clinical research study of BGF MDI 320/14.4/9.6 μg, GFF MDI 14.4/9.6 μg, BGF MDI 160/14.4/9.6 μg and BFF MDI 320/9.6 μg for the treatment of COPD

Georgia

UPDATED

Atlanta Georgia

A clinical research study of BGF MDI 320/14.4/9.6 μg, GFF MDI 14.4/9.6 μg, BGF MDI 160/14.4/9.6 μg and BFF MDI 320/9.6 μg for the treatment of COPD

UPDATED

Columbus Georgia

A clinical research study of BGF MDI 320/14.4/9.6 μg, GFF MDI 14.4/9.6 μg, BGF MDI 160/14.4/9.6 μg and BFF MDI 320/9.6 μg for the treatment of COPD

UPDATED

Duluth Georgia

A clinical research study of BGF MDI 320/14.4/9.6 μg, GFF MDI 14.4/9.6 μg, BGF MDI 160/14.4/9.6 μg and BFF MDI 320/9.6 μg for the treatment of COPD